Cagrilintide 10mg + Semaglutide 10mg 10mg × 10 vials
$200.00
High-dose Cagrilintide and Semaglutide combo peptide for metabolic research.
Buy high-purity Cagrilintide + Semaglutide 10mg × 10 vials online for advanced research in obesity, diabetes, and metabolic studies. Verified purity, fast USA shipping.
Cagrilintide Semaglutide Blend (Research Use Only)
The Cagrilintide + Semaglutide blend is a high-interest research peptide combination designed for advanced metabolic and endocrine studies. At High Purity Peptides, this formulation is supplied as a research-grade compound with 99% purity verified by HPLC and mass spectrometry, alongside a full Certificate of Analysis (COA) for every batch.
This dual-agonist system is widely studied in obesity, glucose regulation, and appetite signaling research, making it a valuable tool in modern peptide science.
What Are Cagrilintide and Semaglutide?
Cagrilintide is an amylin analog, while semaglutide is a GLP-1 receptor agonist. When studied together, they form a synergistic research model that allows scientists to explore multi-pathway metabolic regulation.
In laboratory research, this blend is used to evaluate:
- Appetite suppression mechanisms
- Glucose metabolism regulation
- Gastric emptying delay pathways
- Energy balance and adiposity signaling
Researchers often compare this combination with single-pathway compounds found in GLP-1 peptides to better understand receptor synergy.
Mechanism of Action in Research Models
The Cagrilintide-Semaglutide blend interacts with two distinct hormonal pathways:
- Amylin receptor activation (Cagrilintide): Influences satiety signaling in the brainstem and slows gastric emptying
- GLP-1 receptor activation (Semaglutide): Enhances insulin secretion and reduces appetite signaling
Together, these mechanisms create a multi-target metabolic response that is frequently studied in obesity and diabetes research models.
This dual-pathway interaction is especially relevant when compared with broader metabolic compounds found in the weight loss peptides category.
Research Applications and Scientific Use
In preclinical and laboratory environments, researchers use this blend to investigate:
- Obesity and weight regulation models
- Type 2 diabetes metabolic pathways
- Appetite and satiety signaling studies
- Energy expenditure and lipid metabolism
- Endocrine system receptor interactions
The combination is often evaluated alongside other advanced peptides such as those in the All Peptides catalog for comparative research frameworks.
Formulation, Dosage, and Handling
The Cagrilintide-Semaglutide blend is supplied in a lyophilized powder format for stability and long-term storage.
Key specifications:
- Strength: 10 mg Cagrilintide + 10 mg Semaglutide per vial
- Packaging: Multi-vial research packs
- Storage: -20°C recommended
- Reconstitution: Sterile laboratory-grade water only
This format ensures consistency across experimental batches, supporting reproducible results in metabolic research studies.
Quality Assurance: 99% Purity & COA Verified
Every batch is tested under strict laboratory conditions to ensure:
- 99% purity (HPLC verified)
- Mass spectrometry identity confirmation
- Sterility and endotoxin screening
- Full Certificate of Analysis (COA) included
This level of validation ensures that researchers can rely on consistent, high-quality results across all experimental conditions.
Buy Cagrilintide-Semaglutide Blend Online in Florida, USA
Researchers located in Florida, USA, can buy the Cagrilintide-Semaglutide blend online with fast domestic shipping and full COA documentation included. Orders are processed securely and shipped in temperature-controlled packaging to maintain peptide stability.
For expanded metabolic research, many Florida-based labs also explore complementary compounds such as tirzepatide and other GLP-1-based research tools to build comparative study models.
Related Research Categories
To support broader experimental design, researchers often combine this blend with compounds from:
These categories allow structured research into metabolic pathways and receptor interactions.
Final Research Disclaimer
This product is strictly intended for laboratory and research use only. It is not approved for human or veterinary use, diagnosis, or treatment. All data and descriptions are provided for scientific research purposes only.
